Akros SCHK HK-Korea Biotech Index

The index combines a Hong Kong sleeve of Stock Connect Southbound-eligible stocks with a Korean sleeve of KOSPI- and KOSDAQ-listed stocks from pharmaceutical, medical-device, diagnostics, and related industries, split 62%/38%. Candidates are first ranked by market capitalization and then screened by 6-month average trading volume, yielding 18 Hong Kong and 12 Korean constituents. Constituents are weighted by free-float market capitalization with a 10% cap, and the index is rebalanced semi-annually.